Dicyclomine
Dicyclomine
NADAC/unit
$0.0583
No Shortage
Tier 1: 82.4%
PA Req: 117.9%
20 Manufacturers
31 ANDAs
vs. brand Dicyclomine: Generic saves up to 99% per unit
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
AMERICAN REGENT INCANNORA PHARMA PRIVATE LTDAUROBINDO PHARMA USA INCBIONPHARMA INCCOREPHARMA LLCFOSUN PHARMA USA INCFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALSHIKMA PHARMACEUTICALS USA INCLANNETT CO INCNOVITIUM PHARMA LLCPH HEALTH LTDPRINSTON PHARMACEUTICAL INCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSLATE RUN PHARMACEUTICALS LLCSOMERSET THERAPEUTICS LLCTWI PHARMACEUTICALS INCWATSON LABORATORIES INCWEST WARD PHARMACEUTICAL CORP
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.